NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- ABM (NYSE: ABM), a leading provider of facility, engineering and infrastructure solutions, today announced financial results for its fiscal second quarter ended April 30, 2026.
NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- ABM (NYSE: ABM), a leading provider of facility, engineering and infrastructure solutions, today announced financial results for its fiscal second quarter ended April 30, 2026.
In this article BRK.B Follow your favorite stocks CREATE FREE ACCOUNT watch now VIDEO 48:01 48:01 Buffett disciple Guy Spier’s rare cancer changed what he values most CNBC Cures Noted value investor Guy Spier first gained the public's attention in 2007 when he and a partner paid more than $650,000 at a charity auction to have lunch with the world's most famous value investor, Warren Buffett . Spie...
In this article BRK.B Follow your favorite stocks CREATE FREE ACCOUNT watch now VIDEO 48:01 48:01 Buffett disciple Guy Spier’s rare cancer changed what he values most CNBC Cures Noted value investor Guy Spier first gained the public's attention in 2007 when he and a partner paid more than $650,000 at a charity auction to have lunch with the world's most famous value investor, Warren Buffett . Spier, who calls Buffett his hero, launched his Zurich-based fund Aquamarine in 1997. He mimicked the Oracle of Omaha's investing philosophy , anchored on the premise of compounding interest. Spier hoped the approach would help him build a similarly long-lasting, albeit more modest, investing legacy for Aquamarine. And for years, it worked. From 1997-2025, Aquamarine's total returns outpaced the S&P 500, long seen as the ultimate benchmark for a fund's success. But in November 2024, while returning from a ski trip with his family, a medical emergency forced Spier to confront the realities of his own mortality, and redefine how he decides what holds value in life. "It was a super cold day in November, and on the car journey back to Zurich, I had a grand mal seizure," Spier recalled in an interview for the CNBC Cures' podcast "The Path with Becky Quick." "I was sitting next to my wife in the car. She didn't know what was going on," Spier said during the interview, which was conducted at the recent Berkshire Hathaway annual shareholder meeting. Spier was flown to a hospital where he was given an MRI. "I wake up the next day and I discover that I've got a brain tumor, and my life changed completely on that date," Spier said. It was a grade 4 glioblastoma, an aggressive and fast-growing form of brain cancer. Glioblastomas are rare, impacting roughly 4 out of every 100,000 people . There are no truly effective treatments for the disease, with the median survival for a patient lasting just 15 months after diagnosis. The five-year survival rate is less than 7%. Those figures have not c...
Lululemon Bear Market Deepens After Guidance Cut Spooks Wall Street Lululemon tumbled in New York premarket trading as its multi-year bear market deepened, with shares on track to revisit levels last seen since 2018 after a guidance cut . The struggling athleticwear company now expects full-year revenue of $11 billion to $11.15 billion , below the Bloomberg Consensus estimate of $11.49 billion , w...
Lululemon Bear Market Deepens After Guidance Cut Spooks Wall Street Lululemon tumbled in New York premarket trading as its multi-year bear market deepened, with shares on track to revisit levels last seen since 2018 after a guidance cut . The struggling athleticwear company now expects full-year revenue of $11 billion to $11.15 billion , below the Bloomberg Consensus estimate of $11.49 billion , while its second-quarter sales and profit forecasts also missed the mark. Full Year Forecast (courtesy of Bloomberg): Sees net revenue $11 billion to $11.15 billion, saw $11.35 billion to $11.5 billion, estimates $11.49 billion (Bloomberg Consensus) Sees EPS $10.95 to $11.15, saw $12.10 to $12.30, estimate $12.38 Second Quarter Forecast (courtesy of Bloomberg): Sees net revenue $2.45 billion to $2.48 billion, estimates $2.6 billion Sees EPS $1.76 to $1.81, estimate $2.69 Lululemon's first-quarter results showed modest top-line growth but continued weakness in underlying demand, especially in the Americas. EPS $1.69 vs. $2.60 y/y, estimate $1.69 Net revenue $2.47 billion, +4.3% y/y, estimate $2.44 billion Total comp sales constant currency -2%, estimate -0.23% Americas comp sales in constant currency -6%, estimate -7.14% International Comp Sales Ex-Fx +8%, estimate +13.2% Gross margin 54.2%, estimate 54.6% Operating margin 11.2%, estimate 11.5% Inventory $1.69 billion, estimate $1.8 billion Total location count 816, estimate 818 "We experienced a solid start to 2026 as our teams executed with speed, agility, and discipline. Our work to drive improvements in North America resulted in some positive signals in the quarter, including a sequential improvement in full-price sales," Meghan Frank, Interim Co-CEO and Chief Financial Officer, wrote in a press release. Frank then pointed out, "More recently, we have been navigating headwinds that have led us to adjust our outlook for the full year . We have assessed the business and are taking additional actions to reposition where need...
Navitas Semiconductor solves severe thermal bottlenecks in artificial intelligence server racks by fundamentally transforming power delivery architecture.
Navitas Semiconductor solves severe thermal bottlenecks in artificial intelligence server racks by fundamentally transforming power delivery architecture.
格隆汇6月5日｜高盛集团资产配置研究主管称，在科技股投机性仓位增加后，近期该板块遭到的抛售是一个健康信号。“这是一波非常强劲的上涨行情，极大地推动这些动量股走高，” Christian Mueller-Glissman表示，提及了杠杆ETF和期权头寸增加。“出现一些整理或许并非坏事。”在博通发布令人失望的业绩展望后，Mueller-Glissman警告不应将周期性极强的科技硬件和半导体行业的表现泛...
格隆汇6月5日｜高盛集团资产配置研究主管称，在科技股投机性仓位增加后，近期该板块遭到的抛售是一个健康信号。“这是一波非常强劲的上涨行情，极大地推动这些动量股走高，” Christian Mueller-Glissman表示，提及了杠杆ETF和期权头寸增加。“出现一些整理或许并非坏事。”在博通发布令人失望的业绩展望后，Mueller-Glissman警告不应将周期性极强的科技硬件和半导体行业的表现泛化。在他看来，如果投资者开始质疑今年迄今推动市场上涨的强劲盈利增长，将是股市面临的最大威胁。